25 May 2013
Keywords: Erlotinib, Celecoxib, Head and neck cancer, Emory University
Article | 20 February 2013
A new drug combination shows promise in reducing the risk for patients with advanced oral precancerous lesions to develop squamous ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 February 2013
21 February 2013
24 May 2013
© 2013 thepharmaletter.com